Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesCurrent DebtDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $1.9 billion.

  • Fresenius Medical Care AG's Depreciation & Amortization (CF) rose 4.37% to $418.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year decrease of 3.50%. This contributed to the annual value of $1.9 billion for FY2024, which is 1.76% down from last year.
  • Fresenius Medical Care AG's Depreciation & Amortization (CF) amounted to $1.9 billion in FY2024, which was down 1.76% from $1.9 billion recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Depreciation & Amortization (CF) registered a high of $2.0 billion during FY2020, and its lowest value of $1.9 billion during FY2024.
  • Over the past 3 years, Fresenius Medical Care AG's median Depreciation & Amortization (CF) value was $1.9 billion (recorded in 2023), while the average stood at $1.9 billion.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first rose by 14.28% in 2020, then decreased by 5.77% in 2021.
  • Over the past 5 years, Fresenius Medical Care AG's Depreciation & Amortization (CF) (MRY) stood at $2.0 billion in 2020, then dropped by 5.77% to $1.9 billion in 2021, then grew by 0.84% to $1.9 billion in 2022, then fell by 2.19% to $1.9 billion in 2023, then dropped by 1.76% to $1.9 billion in 2024.
  • Its Depreciation & Amortization (CF) was $1.9 billion in FY2024, compared to $1.9 billion in FY2023 and $1.9 billion in FY2022.